Nano-X Imaging Ltd.

Nano-X Imaging Ltd.

NNOX
Nano-X Imaging Ltd.US flagNASDAQ Global Market
0.98
USD
-0.10
- -
68.13MMarket Cap
Nano-X Imaging Ltd.
NNOX
(NASDAQ Global Market)

Recent

price

0.98

P/E

ratio

- -

div

yld

- -

ROIC.AI

2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
- -
0.03
0.16
0.18
0.19
0.2
0.22
Revenue per Share
-0.06
-0.66
-1.23
-1.28
-2.17
-1.08
-0.91
-1.16
-1.15
Basic EPS, GAAP
-0.11
-0.17
-1
-1.27
-0.97
-0.85
-0.67
-0.69
-0.75
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.53
-1.19
-2.36
-3.03
-4.96
-5.68
-6.37
-6.92
-6.99
Book Value per Share
-0.19
-0.26
6.47
2.74
2.26
2.04
2.03
1.23
1.04
Tangible Book Value per Share
34
34
36
48
52
56
59
65
66
Basic Weighted Avg Shares
- -
- -
- -
1
9
10
11
13
15
Sales/Revenue/Turnover
- -
- -
- -
-4,720.71
-1,016.65
-602.29
-502.93
-466.16
-421.15
Operating Margin (%)
- -
- -
- -
2
12
12
12
12
12
Depreciation Expense
-2
-23
-44
-62
-113
-61
-54
-75
-76
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
-4,739.11
-1,320.16
-613.59
-474.31
-576.13
-523.83
Profit Margin (%)
-7
-11
215
42
57
73
65
50
37
Working Capital
- -
- -
1
5
4
4
4
4
4
LT Debt
-6
-9
231
292
217
196
189
140
126
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
4
4
4
LT Borrowings
- -
- -
- -
LT Finance Leases
4
4
4
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
65
70
70
Market Capitalization
233
181
150

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
51
67
51
Cash, Cash Equivalents & STI
45
60
44
Accounts Receivable, Net
2
2
2
Inventories
3
3
3
Total Current Liabilities
12
17
14
Payables & Accruals
4
7
6
ST Debt
4
4
4
Deferred Revenue
- -
1
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-7.67%
-26.11%
Free Cash Flow
- -
9.22%
14.31%
Net Income, GAAP
- -
21.24%
40.18%
Sales/Revenue/Turnover
- -
- -
15.4%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3
3
3
3
11
2025
3
3
3
4
13
2026
4
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.21
-0.23
-0.23
-0.23
-0.91
2025
-0.21
-0.23
-0.21
-0.5
-1.16
2026
-0.2
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Nano-X Imaging Ltd. (NASDAQ: NNOX) develops and commercializes innovative medical imaging systems leveraging proprietary digital X-ray source technology to enable cost-effective, high-resolution tomographic imaging. The company offers the Nanox.ARC, an FDA-cleared, CE-marked digital multi-source 3D tomosynthesis imaging system for advanced radiographic visualization; the Nanox.ARC X, its next-generation FDA-cleared digital multi-source 3D tomosynthesis system with enhanced image detail and platform capabilities; Nanox.AI solutions, including FDA-cleared AI algorithms for cardiac, bone, and liver applications to detect asymptomatic chronic diseases; Nanox.SOURCE, a silicon-based nano-scale cold cathode X-ray source; and the Nanox.MARKETPLACE platform connecting imaging providers for global teleradiology services. Headquartered in Israel and founded in 2011, Nano-X Imaging operates primarily in the medical imaging sector, targeting healthcare providers, hospitals, and diagnostic facilities worldwide with a focus on improving global health equity through accessible advanced diagnostics. In recent developments, the company announced an agreement on November 19, 2025, to acquire VasoHealthcare IT from Vaso Corporation for up to $800,000 to bolster U.S. AI expansion; extended its collaboration with USARAD Holdings for advanced radiology diagnostics; partnered with Czech distributor EXRAY to penetrate over 50% of the Czech imaging market with Nanox.ARC sales and service; and completed a $15 million registered direct offering of ordinary shares to support growth initiatives, alongside reporting Q2 2025 revenue of $3.0 million.

Company News

APIChatGPT
  • DEADLINE ALERT for ERAS, NNOX, MSFT, BRCB: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

  • Robbins LLP Urges NNOX Stockholders to Contact the Firm for Information About the Class Action Against Nano-X Imaging Ltd

  • NNOX Shareholder Alert: Nano-X Imaging Ltd. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

  • ROSEN, A LEADING LAW FIRM, Encourages Nano-X Imaging Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NNOX

  • Deadline Alert: Nano-X Imaging Ltd. (NNOX) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

  • Pomerantz Law Firm Announces the Filing of a Class Action Against Nano-X Imaging Ltd. and Certain Officers – NNOX

  • Bronstein, Gewirtz & Grossman LLC Urges Nano-X Imaging Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

  • Portnoy Law Firm Announces Class Action on Behalf of Nano-X Imaging Ltd. Investors

  • NNOX Investors Have Opportunity to Lead Nano-X Imaging Ltd. Securities Fraud Lawsuit with the Schall Law Firm

  • SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2026 in Nano-X Imaging Ltd. Lawsuit - NNOX

  • NNOX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Nano-X Imaging Ltd. Securities Lawsuit - Contact The Gross Law Firm

  • NNOX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Nano-X Imaging (NNOX) Investors of Securities Class Action Lawsuit Deadline on August 11, 2026

  • NNOX Investors Have Opportunity to Lead Nano-X Imaging Ltd. Securities Fraud Lawsuit

  • Bronstein, Gewirtz & Grossman LLC Urges Nano-X Imaging Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

  • Levi & Korsinsky Reminds Nano-X Imaging Ltd. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 11, 2026 - NNOX

  • ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Nano-X Imaging Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NNOX

  • NNOX CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Nano-X Imaging (NNOX) Investors of Securities Class Action Lawsuit Deadline on August 11, 2026

  • Bronstein, Gewirtz & Grossman LLC Urges Nano-X Imaging Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

  • ROSEN, A LONGSTANDING FIRM, Encourages Nano-X Imaging Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NNOX

  • ROSEN, REGARDED INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NNOX